Featured Research

from universities, journals, and other organizations

Genetic Polymorphisms, Antidepressant Use May Be Associated With Altered Tamoxifen Activity

Date:
January 21, 2005
Source:
Journal Of The National Cancer Institute
Summary:
Interactions between certain genetic polymorphisms and antidepressants called selective serotonin reuptake inhibitors (SSRIs) may be associated with altered tamoxifen activity, according to a new study in the January 5 issue of the Journal of the National Cancer Institute.

Interactions between certain genetic polymorphisms and antidepressants called selective serotonin reuptake inhibitors (SSRIs) may be associated with altered tamoxifen activity, according to a new study in the January 5 issue of the Journal of the National Cancer Institute.

Related Articles


Tamoxifen is widely used for the treatment of all stages of hormone receptor–positive breast cancer and has now also been approved for use in the prevention of breast cancer in women at high risk of the disease. However, the efficacy of tamoxifen treatment for breast cancer varies widely among women. The drug is metabolized by several cytochrome P450 (CYP) enzymes, including CYP2D6. Some SSRIs, which are commonly prescribed to treat hot flashes in women who take tamoxifen, are known to inhibit CYP2D6.

To examine the effects of SSRI use and variations of the CYP2D6 allele on plasma concentrations of tamoxifen and its metabolites, David A. Flockhart, M.D., Ph.D., of the Indiana University School of Medicine in Indianapolis, and colleagues studied 80 women with newly diagnosed breast cancer who were beginning tamoxifen therapy. Twenty-four of these women were taking an SSRI during their treatment. The researchers genotyped the women for common alleles of CYP2D6 and several other genes that encode tamoxifen-metabolizing enzymes and measured plasma concentrations of tamoxifen and its metabolites.

After 4 months of tamoxifen therapy, women carrying one or two copies of a CYP2D6 variant allele had lower plasma concentrations of endoxifen (an active tamoxifen metabolite) than women with the homozygous wild-type genotype. Among women carrying two copies of the wild-type CYP2D6 allele, the plasma endoxifen concentration was 58% lower in women taking an SSRI than in women who were not taking the drug. The authors conclude that interactions between CYP2D6 polymorphisms and some SSRIs may be associated with altered tamoxifen activity.

"SSRIs are likely to gain increasing importance as therapeutic alternatives to estrogen for the treatment of hot flashes in patients with breast cancer as well as in unaffected women, in addition to their already established role in treatment of depression and other psychiatric illnesses. It is possible that testing of CYP2D6 genetic variants and careful attention to use of CYP2D6 inhibitors may help identify a group of women who may experience greater benefit from tamoxifen and/or who might benefit more from treatment with one SSRI over another. Firm clinical recommendations about which SSRI to use and whether genotype predicts clinical response of tamoxifen must await results from definitive clinical trials," the authors write.

###

Citation: Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee K-H, et al. Association Between CYP2D6 Genotype and Antidepressants, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment. J Natl Cancer Inst 2004;97:30–39.

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oupjournals.org/.


Story Source:

The above story is based on materials provided by Journal Of The National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal Of The National Cancer Institute. "Genetic Polymorphisms, Antidepressant Use May Be Associated With Altered Tamoxifen Activity." ScienceDaily. ScienceDaily, 21 January 2005. <www.sciencedaily.com/releases/2005/01/050111122247.htm>.
Journal Of The National Cancer Institute. (2005, January 21). Genetic Polymorphisms, Antidepressant Use May Be Associated With Altered Tamoxifen Activity. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2005/01/050111122247.htm
Journal Of The National Cancer Institute. "Genetic Polymorphisms, Antidepressant Use May Be Associated With Altered Tamoxifen Activity." ScienceDaily. www.sciencedaily.com/releases/2005/01/050111122247.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins